Lipofectin-facilitated transfer of cholecystokinin gene corrects behavioral abnormalities of rats with audiogenic seizures

Neuroscience

Volumn 77, Issue 1, 1997, Pages 15-22

  Zhang, L X ^a,b   Li, X L ^a,b   Smith, M A ^b   Post, R M ^b   Han, J S ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Analgesia; CCK; Epilepsy; Gene therapy; Gene transfer; Liposome

Indexed keywords

CHOLECYSTOKININ; LIPOSOME; MESSENGER RNA;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUDIOGENIC SEIZURE; BEHAVIOR; CONTROLLED STUDY; EPILEPSY; GENE TRANSFER; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ACOUSTIC STIMULATION; ANIMALS; AUTORADIOGRAPHY; BEHAVIOR, ANIMAL; DNA, COMPLEMENTARY; EPILEPSY; GENE TRANSFER TECHNIQUES; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIPOSOMES; MALE; MICROINJECTIONS; PHOSPHATIDYLETHANOLAMINES; PLASMIDS; RATS; RATS, MUTANT STRAINS; RATS, WISTAR; RNA, MESSENGER; SEIZURES; SINCALIDE;

EID: 0031035730     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(96)00420-4     Document Type: Article

References (36)

1. Akli S., Caillaud C., Vigne E., Stratford P. L., Poenaru L., Perricaudet M., Kahn A., Peschanski M. R. Transfer of a foreign gene into the brain using adenovirus vectors [see comments]. Nature Genet. 3:1993;224-228.
2. Bajocchi G., Feldman S. H., Crystal R. G., Mastrangeli A. Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors [see comments]. Nature Genet. 3:1993;229-234.
3. 14C]insulin after intrathecal infusion. Brain Res. 52:1973;323-332.
4. Bowsher D. Pathway of absorption of proteins from the cerebrospinal fluid: an autoradiographic study in the cat. Anat. Res. 128:1957;23-39.
5. Chen X. H., Han J. S., Huang L. T. CCK receptor antagonist L-365,260 potentiated electroacupuncture analgesia in Wistar rats but not in audiogenic epileptic rats. Chin. med. J. (Engl. Transl.). 107:1994;113-118.
6. Debs R. L., Freedman L., Edmunds S., Yamamoto K. Regulation of gene expression in vivo by liposome-based delivery of a purified transcription factor. J. biol. Chem. 265:1990;10189-10192.
7. Deschenes R. J., Lorenz L. J., Haun R. S., Roos B. A., Collier K. J., Dixon J. E. Cloning and sequence analysis of a cDNA encoding rat preprocholecystokinin. Proc. natn. Acad. Sci. U.S.A. 81:1984;726-730.
8. Faris P. L., Komisaruk B. R., Watkins L. R., Mayer D. J. Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia. Science. 219:1983;310-312.
9. Felgner P. L., Northrop J. P., Ringold G. M., Danielsen M. A highly efficient, lipid-mediated DNA transfection procedure. Proc. natn. Acad. Sci. U.S.A. 84:1987;7413-7417.
10. Fink D. J., Sterberg L. R., Weber P. C., Mata M., Goins W. F., Glorioso J. C. In vivo expression of β-galatosidase in hippocampal neurons by HSV-mediated gene transfer. Human Gene Ther. 3:1992;11-20.
11. Geller A. I., Keyomarsi K., Bryan J., Pardee A. B. An efficient deletion mutant packaging system for defective herpes simplex virus vectors: potential applications to human gene therapy and neuronal physiology. Proc. natn. Acad. Sci. U.S.A. 87:1990;8950-8954.
12. Han J. S., Ding X. Z., Fan S. G. Is cholecystokinin octapeptide (CCK-8) a candidate for endogenous anti-opioid substance? Neuropeptides. 5:1985;399-402.
13. Ho D. Y., Mocarski E. S., Sapolsky R. M. Altering central nervous system physiology with a defective herpes simplex virus vector expressing the glucose transporter gene. Proc. natn. Acad. Sci. U.S.A. 90:1993;3655-3659.
14. Itoh S., Katsuura G., Maeda Y. Caerulein and cholecystokinin suppress β-endorphin-induced analgesia in the rat. Eur. J. Pharmac. 80:1980;421-425.
15. Jiao S., Acsadi G., Jani A., Felgner P. L., Wolff J. A. Persistence of plasmid DNA and expression in rat cells in vivo. Expl Neurol. 115:1992;400-413.
16. Kadar T., Borda L., Zarandi M., Penke B., Kovacs K., Telegdy G. Inhibition of electroshock-induced seizures by cholecystokinin-related peptides in mice. Acta physiol. hung. 69:1987;43-50.
17. Kadar T., Pesti A., Peuke B. Inhibition of seizures induced by picrotoxin and electroshock by cholecystokinin octapeptide and their fragments in rats after intracerebroventricular administration. Neuropharmacology. 23:1984;955-961.
18. Kaplitt M. G., Leone P., Samulski R. J., Xiao X., Pfaff D. W., O'Malley K. L., During J. M. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nature Genet. 8:1994;148-154.
19. Kaplitt M. G., Pfaus J. G., Kleopoulos S. P., Hanlon B. A., Rabkin S. D., Pfaff D. W. Expression of a functional foreign gene in adult mammalian brain following in vivo transfer via a herpes simplex virus type 1 defective viral vector. Molec. cell. Neurosci. 2:1991;320-330.
20. Malone R., Felgner P. L., Velma I. Cationic liposome mediated RNA transfection. Proc. natn. Acad. Sci. U.S.A. 86:1989;6077-6081.
21. Ono T., Fujino Y., Tsuchiya T., Tsuda M. Plasmid DNAs directly injected into mouse brain with lipofectin can be incorporated and expressed by brain cells. Neurosci. Lett. 117:1990;259-263.
22. Palmer T. D., Rosman G. J., Osborne W. R. A., Miller A. D. Genetically modified skin fibroblasts persist long after transplatation but gradually inactivate introduced genes. Proc. natn. Acad. Sci. U.S.A. 88:1991;1330-1334.
23. Pardrige W. Strategies for drug delivery through the blood-brain barrier. Neurobiol. Aging. 10:1989;636-637.
24. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic, Sydney.
25. Ren M. F., Han J. S. Rat tail flick acupucture analgesia model. Chin. med. J. (Engl. Transl.). 92:1979;576-582.
26. Roessler B. J., Davidson B. L. Direct plasmid mediated transfection of adult murine brain cells in vivo using cationic liposomes. Neurosci. Lett. 167:1994;5-10.
27. Whitfield H. J., Brady L. S., Smith M. A., Mamalaki E., Fox R. J., Herkenham M. Optimization of cRNA probe in situ hybridization methodology for localization of glucocorticoid receptor mRNA in rat brain: a detailed protocol. Cell. molec. Neurobiol. 10:1990;145-157.
28. Wu X. R., Lin P. X. Effects of cholecystokinin octapeptide on genetically determined seizure susceptibility. Chin. med. J. (Engl. Transl.). 105:1992;110-115.
29. Xu L., Yee J. K., Wolff J. A., Friedmann T. Factors affecting long-term stability of moloney murine leukemia virus-based vectors. Virology. 171:1989;331-341.
30. Yang K., Faustinella F., Xue J. J., Whitson J., Kampfl A., Mu X. S., Zhao X., Taglialatela G., Perez-Polo J. R., Clifton G., Hayes R. L. Optimizing liposome-mediated gene transfer in primary rat septo-hippocampal cell cultures. Neurosci. Lett. 182:1994;287-290.
31. Yang K., Faustinella F., Xue J. J., Whitson J., Kampfl A., Mu X. S., Zhao X., Taglialatela G., Perez-Polo J. R., Clifton G., Hayes R. L. Sustained expression of functional nerve growth factor in primary septo-hippocampal cell cultures by liposome-mediated gene transfer. Neurosci. Lett. 182:1994;291-294.
32. Zetler G. Anticonvulsant effects of caerulei and cholecystokinin octapeptide (CCK-8) and diazepam against seizures produced in mice by harman, thiosemicarbazide and isoniazid. Neurosci. Lett. 24:1981;175-179.
33. Zhang L. X., Smith M. A., Kim S. Y., Rosen J. B., Weiss S. R. B., Post R. M. Changes in cholecystokinin mRNA expression after amygdala kindled seizures: an in situ hybridization study. Molec. Brain Res. 35:1996;278-284.
34. Zhang L. X., Wu M., Han J. S. Suppression of audiogenic epileptic seizures by intracerebral injection of a CCK gene vector. NeuroReport. 3:1992;700-702.
35. Zhang L. X., Zhou Y., Du Y., Han J. S. Effect of CCK-8 on audiogenic epileptic seizure in P77PMC rats. Neuropeptides. 25:1993;73-76.
36. Zhao D., Wu X. R., Pi Y. Q. Long-term effect of febrile convulsion on seizure susceptibility in P77PMC rat resistant to acoustic stimuli but susceptible to kainate-induced seizure. Expl Neurol. 88:1985;668-670.